Meeder Asset Management Inc Kala Pharmaceuticals, Inc. Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$7.5 - $11.11 $4,170 - $6,177	-556 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$8.33 - $13.79 $18,492 - $30,613	-2,220 Reduced 79.97%	556 $6,000
Q1 2020 May 15, 2020	BUY	$3.83 - $8.79 $10,632 - $24,401	2,776 New	2,776 $24,000
Q4 2019 Feb 13, 2020	SELL	$3.36 - $4.81 $6,810 - $9,749	-2,027 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$3.57 - $6.58 $2,142 - $3,948	600 Added 42.05%	2,027 $8,000
Q2 2019 Aug 05, 2019	BUY	$4.93 - $8.8 $1,084 - $1,936	220 Added 18.23%	1,427 $9,000
Q1 2019 Apr 16, 2019	SELL	$5.19 - $8.97 $4,141 - $7,158	-798 Reduced 39.8%	1,207 $10,000
Q4 2018 Jan 17, 2019	BUY	$4.29 - $9.94 $7,807 - $18,090	1,820 Added 983.78%	2,005 $9,000
Q3 2018 Nov 02, 2018	BUY	$9.54 - $13.87 $1,764 - $2,565	185 New	185 $0

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.08M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.